Navarro Tulio Pinho, Bernardes Rodrigo de Castro, Procopio Ricardo Jayme, Leite Jose Oyama, Dardik Alan
Federal University of Minas Gerais, Panamerican Circulation Institute, Belo Horizonte, Minas Gerais, Brazil;
Madre Teresa Hospital Aortic Center, Panamerican Circulation Institute, Belo Horizonte, Minas Gerais, Brazil; and.
Aorta (Stamford). 2014 Feb 1;2(1):28-36. doi: 10.12945/j.aorta.2014.13-030. eCollection 2014 Feb.
Endovascular aneurysm repair (EVAR) is a therapy that continues to evolve rapidly as advances in technology are incorporated into new generations of devices and surgical practice. Although EVAR has emerged as a safe and effective treatment for patients with favorable anatomy, treatment of patients with unfavorable anatomy remains controversial and is still an off-label indication for endovascular treatment with some current stent-grafts. The proximal neck of the aneurysm remains the most hostile anatomic barrier to successful endovascular repair with long-term durability. Open surgery for unfavorable necks is still considered the gold standard treatment in contemporary practice, despite the increased mortality and morbidity attributed to suprarenal cross-clamping, particularly in high-risk patients. Evolving technology may overcome the obstacles preventing endovascular treatment of unfavorable proximal neck anatomy; current approaches include purely endovascular as well as hybrid approaches, and generally include strategies that either extend the length of the short neck, move the proximal neck more proximally, or keep the short neck intact. These approaches include the use of debranching techniques, banding, chimneys, fenestrated and branched devices, filling the sac with endobags, endoanchors, and other novel devices. These newer-generation devices appear to have promising short- and midterm results. However, lack of good evidence of efficacy with long-term results for these newer approaches still precludes wide dissemination of endovascular solutions for the hostile proximal neck.
血管内动脉瘤修复术(EVAR)是一种随着技术进步被应用于新一代器械和手术操作中而持续快速发展的治疗方法。尽管EVAR已成为解剖结构有利患者的一种安全有效的治疗方法,但解剖结构不利患者的治疗仍存在争议,并且对于一些当前的覆膜支架而言,这仍是血管内治疗的一种超适应证。动脉瘤的近端颈部仍然是成功进行具有长期耐久性的血管内修复的最不利解剖学障碍。尽管由于肾上交叉阻断,尤其是在高危患者中,死亡率和发病率有所增加,但在当代实践中,针对不利颈部的开放手术仍被视为金标准治疗方法。不断发展的技术可能会克服阻碍对不利近端颈部解剖结构进行血管内治疗的障碍;当前的方法包括单纯血管内方法以及杂交方法,并且通常包括延长短颈长度、将近端颈部向更靠近近端移动或保持短颈完整的策略。这些方法包括使用去分支技术、束带术、烟囱技术、开窗和分支器械、用封堵球囊填充瘤腔、腔内锚定器及其他新型器械。这些新一代器械似乎具有良好的短期和中期效果。然而,这些新方法缺乏长期疗效的确凿证据,这仍然阻碍了针对不利近端颈部的血管内解决方案的广泛应用。